| P2093 | author name string | Kinghorn GR | |
| | Morton RS | |
| P2860 | cites work | Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients | Q24561668 |
| | Tolerance, danger, and the extended family | Q29547532 |
| | Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic | Q35541320 |
| | Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia | Q36512610 |
| | Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline | Q37093492 |
| | Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis | Q37362297 |
| | Monitoring of Chlamydia trachomatis infections after antibiotic treatment using RNA detection by nucleic acid sequence based amplification | Q37641088 |
| | Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study | Q37878617 |
| | Can degenerative aortic valve stenosis be related to persistent Chlamydia pneumoniae infection? | Q37879600 |
| | High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. | Q37880679 |
| | Chlamydia pneumoniae in human abdominal aortic aneurysms | Q37881211 |
| | The effect of prolonged doxycycline therapy on Chlamydia pneumoniae serological markers, coronary heart disease risk factors and forearm basal nitric oxide production | Q37881386 |
| | Chlamydia trachomatis genotypes: correlation with clinical manifestations of infection and patients' characteristics | Q37881407 |
| | Induction of macrophage foam cell formation by Chlamydia pneumoniae | Q37881436 |
| | Humoral immune response to conserved epitopes of Chlamydia trachomatis and human 60-kDa heat-shock protein in women with pelvic inflammatory disease | Q37881443 |
| | Can serology diagnose upper genital tract Chlamydia trachomatis infections? Studies on women with pelvic pain, with or without chlamydial plasmid DNA in endometrial biopsy tissue | Q37881732 |
| | Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. A use-effectiveness study in public health settings | Q37881738 |
| | Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is this true for humans? | Q37881794 |
| | Severe disease in children with trachoma is associated with persistent Chlamydia trachomatis infection | Q37881922 |
| | Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group | Q37882250 |
| | Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 |
| | Spontaneous clearance of Chlamydia trachomatis infection in untreated patients | Q37883187 |
| | Inhibition of intracellular multiplication of human strains of Chlamydia trachomatis by nitric oxide | Q37883224 |
| | Chlamydial pelvic inflammatory disease | Q37884120 |
| | : Risk factors for seropositivity and association with coronary heart disease | Q37887420 |
| | Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease | Q37889237 |
| | Recurrent genitourinary chlamydial infections in sexually active female adolescents | Q37892528 |
| | Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study | Q37893723 |
| | Antibiotic Treatment of Venereal Disease and Reiter's Syndrome in a Greenland Population | Q37893765 |
| | Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy | Q37899095 |
| | The therapy of experimental psittacosis and lymphogranuloma venereum (inguinale) II. The activity of quinoxaline-1:4-dioxide and substituted and related compounds, with a note on the morphological changes induced in lymphogranuloma virus by these co | Q37918452 |
| | Clostridium defficiel in the urogenital tract of males and females | Q39327575 |
| | Acute anterior uveitis in men. Association with chronic prostatitis | Q39750168 |
| | Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis | Q40505134 |
| | The therapy of experimental psittacosis and lymphogranuloma venereum (inguinale). I. The comparative efficacy of penicillin, chloramphenicol, aureomycin, and terramycin | Q41812062 |
| | Fluctuations of HIV load in semen of HIV positive patients with newly acquired sexually transmitted diseases | Q41953675 |
| | Chlamydia trachomatis and sexually transmitted disease | Q42687807 |
| | Problems with non-gonococcal urethritis. | Q43432980 |
| | Cell mediated immunity in Chagas' disease: Trypanosoma cruzi antigens induce suppression of the in vitro proliferative response of mononuclear cells | Q43879940 |
| | Efficacy of combined metronidazole and triple tetracycline therapy in the treatment of non-gonococcal urethritis | Q43978429 |
| | Polly Matzinger: immunology's dangerous thinker | Q48827026 |
| | Ueber eine bisher unerkannte Spirochäteninfektion (Spirochaetosis arthritica) | Q56603620 |
| P433 | issue | 12 | |
| P304 | page(s) | 765-775 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | International Journal of STD & AIDS | Q15716692 |
| P1476 | title | Genitourinary chlamydial infection: a reappraisal and hypothesis | |
| P478 | volume | 10 | |